Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$40.97 - $43.33 $887,246 - $938,354
21,656 New
21,656 $916,000
Q4 2019

Feb 14, 2020

SELL
$74.18 - $97.92 $245,239 - $323,723
-3,306 Closed
0 $0
Q3 2019

Nov 14, 2019

BUY
$75.36 - $86.57 $16,729 - $19,218
222 Added 7.2%
3,306 $249,000
Q2 2019

Aug 14, 2019

BUY
$83.92 - $108.88 $43,722 - $56,726
521 Added 20.33%
3,084 $263,000
Q1 2019

May 15, 2019

BUY
$85.97 - $108.09 $220,341 - $277,034
2,563 New
2,563 $277,000
Q1 2018

May 15, 2018

SELL
$95.91 - $107.26 $2.48 Million - $2.78 Million
-25,898 Closed
0 $0
Q4 2017

Feb 14, 2018

BUY
$104.5 - $126.38 $2.71 Million - $3.27 Million
25,898
25,898 $2.71 Million

Others Institutions Holding TARO

About TARO PHARMACEUTICAL INDUSTRIES LTD


  • Ticker TARO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 37,584,600
  • Description
  • Taro Pharmaceutical Industries Ltd., a science-based pharmaceutical company, develops, manufactures, and markets prescription and over-the-counter pharmaceutical products in the United States, Canada, Israel, and internationally. The company also develops and manufactures active pharmaceutical ingredients primarily for use in its finished dosage...
More about TARO
Track This Portfolio

Track Squarepoint Ops LLC Portfolio

Follow Squarepoint Ops LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

News

Stay updated on Squarepoint Ops LLC with notifications on news.